Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

Autor: Andersen, N.S., Bornhauser, M., Gramatzki, M., Dreger, P., Vitek, A., Karas, M., Michallet, M., Moreno, C., Gelder, M. van, Henseler, A., Wreede, L.C. de, Schonland, S., Kroger, N., Schetelig, J., CLL subcomm Chronic

Publikováno v: Journal of Cancer Research and Clinical Oncology, 145(11), 2823-2834. Springer, Cham
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Cancer Research and Clinical Oncology, 145(11), 2823-2834

Purpose The optimal dose intensity for conditioning prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) for chronic lymphocytic leukemia (CLL) is unknown. Methods We retrospectively compared outcomes of patients who received a firs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f631c051d7bdab9b34831ad648cdb5
https://cris.maastrichtuniversity.nl/en/publications/a1fac50b-1c19-4917-b2bc-73d4fd021987

Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Autor: Gelder, M. van, Ziagkos, D., Wreede, L. de, Biezen, A. van, Dreger, P., Gramatzki, M., Stelljes, M., Andersen, N.S., Schaap, N., Vitek, A., Beelen, D., Lindstrom, V., Finke, J., Passweg, J., Eder, M., Machaczka, M., Delgado, J., Kruger, W., Raida, L., Socie, G., Jindra, P., Afanasyev, B., Wagner, E., Chalandon, Y., Henseler, A., Schoenland, S., Kroger, N., Schetelig, J., CLL Subcomm Chronic Malignancies W, European Soc Blood Marrow Transpla

Publikováno v: Clinical Lymphoma, Myeloma and Leukemia, 17(10), 667
Clinical Lymphoma Myeloma & Leukemia, 17, 10, pp. 667
Clinical Lymphoma Myeloma & Leukemia, 17, 667
Clinical Lymphoma Myeloma & Leukemia, 17(10), 667-675.e2. CIG Media Group, L.P.

Patients with chronic lymphocytic leukemia with del(17p) or del(11q) have poor long-term prognosis with targeted therapies. Conversely, this retrospective European Society for Blood and Marrow Transplantation registry study shows that young high cyto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4036066a092faaccd21d460720acb7d5
https://hdl.handle.net/1887/115783

Impact of procedure related factors and center effects on outcome of CLL transplantations

Autor: Schetelig, J., Wreede, L. de, Gelder, M. van, Andersen, N.S., Moreno, C., Vitek, A., Karas, M., Michallet, M., Machaczka, M., Gramatzki, M., Beelen, D., Finke, J., Delgado, J., Volin, L., Passweg, J., Dreger, P., Henseler, A., Biezen, A. van, Bornhauser, M., Schonland, S.O., Kroger, N., CLL Subcomm, Chronic Malignancies Working Party

Publikováno v: Bone Marrow Transplantation, 51, S72-S73

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c5410efad964a8db2f52d3c7c34a1deb
https://hdl.handle.net/1887/113025

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.